Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pathological analysis of muscle hypertrophy and degeneration in muscular dystrophy in gamma-sarcoglycan-deficient mice.

Neuromuscular disorders : NMD - 1 Mar 2003

Sasaoka Toshikuni, Imamura Michihiro, Araishi Kenji, Noguchi Satoru, Mizuno Yuji, Takagoshi Naomi, Hama Hiroshi, Wakabayashi-Takai Eriko, Yoshimoto-Matsuda Yukiko, Nonaka Ikuya, Kaneko Kiyotoshi, Yoshida Mikiharu, Ozawa Eijiro

Abstract excerpt

While calf muscle hypertrophy is a striking diagnostic finding in sarcoglycanopathy, as it is in Duchenne and Becker muscular dystrophies, its pathogenetic mechanism remains unknown. gamma-Sarcoglycan, one of the subunits of the sarcoglycan complex, is the protein responsible for gamma-sarcoglycanopathy. To elucidate the pathogenetic mechanisms of muscle hypertrophy and degeneration in muscular dystrophy, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Basement Membrane
Share to Dystroglycans

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Growth Substances

Share to Hypertrophy

Share to Muscle Fibers, Skeletal

Share to Muscular Dystrophy, Animal

Share to Sarcoglycans

Share to Survival

Source

Identifiers

PMID: 12609501
DOI: 10.1016/s0960-8966(02)00220-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pathological analysis of muscle hypertrophy and degeneration in muscular dystrophy in gamma-sarcoglycan-deficient mice.PMID 12609501Read ↗

Overexpression of gamma-sarcoglycan induces severe muscular dystrophy. Implications for the regulation of Sarcoglycan assembly.Semantic proximity Read ↗

Muscle degeneration without mechanical injury in sarcoglycan deficiencySemantic proximity Read ↗

Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice.Semantic proximity Read ↗

Systemic γ-sarcoglycan AAV gene transfer results in dose-dependent correction of muscle deficits in the LGMD 2C/R5 mouse modelSemantic proximity Read ↗

Rescue of skeletal muscles of gamma-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer.Semantic proximity Read ↗

Myostatin blockade improves function but not histopathology in a murine model of limb‐girdle muscular dystrophy 2CSemantic proximity Read ↗

Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex.Semantic proximity Read ↗

Excess SMAD signaling contributes to heart and muscle dysfunction in muscular dystrophy.Semantic proximity Read ↗

zeta-Sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophySemantic proximity Read ↗

Sarcoglycans in muscular dystrophy.Semantic proximity Read ↗

Genetically Engineered Mouse Models Unveil Mechanisms and Therapeutic Strategies for GMPPB-Associated DystroglycanopathySemantic proximity Read ↗

Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx miceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.